Softwr

Healthcare · head to head

PathAI vs STARLIMS

PathAI logo

PathAI

Healthcare

Digital pathology image management with an FDA cleared platform for primary diagnosis

From
On request
Rated
-
Full reviewWebsite
STARLIMS logo

STARLIMS

Research

Laboratory information management from Abbott for regulated and public health labs

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: PathAI aISight is labelled research use only and cannot be used for primary diagnosis; only AISight Dx carries the FDA clearance and CE-IVD mark, and laboratories regularly buy the wrong configuration and discover they cannot sign out on it.; STARLIMS implementation is lengthy and outcome quality depends heavily on the partner doing the configuration
  • They diverge on capability: PathAI covers AISight image management, STARLIMS covers Sample and specimen management.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which PathAI and STARLIMS actually diverge.

Attributes where PathAI and STARLIMS differ
AttributePathAISTARLIMS
PlatformsWebWeb, Windows, Cloud, On-premise
CategoryHealthcareResearch

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in PathAI

  • AISight image management
  • AISight Dx
  • Scanner interoperability
  • Case and worklist management
  • AI algorithm deployment
  • Biopharmaceutical research tooling
  • LIS integration

Only in STARLIMS

  • Sample and specimen management
  • Quality management
  • Instrument integration
  • Public health reporting
  • Regulatory compliance
  • Web and mobile access

What people use each for

The jobs each tool is most often brought in to do.

PathAI

  • An academic medical centre going digital for primary diagnosis that needs the FDA cleared AISight Dx configuration rather than the research labelled versionnot STARLIMS
  • A reference laboratory consolidating subspecialty sign out across sites so a specialist pathologist can read cases from any locationnot STARLIMS
  • A pharmaceutical company needing consistent quantitative scoring of trial biopsies across many sites and readersnot STARLIMS
  • A laboratory with a mixed scanner estate that needs one image management layer rather than each scanner vendor viewernot STARLIMS

STARLIMS

  • Public health laboratories handling surveillance and outbreak investigationnot PathAI
  • Clinical laboratories needing regulated specimen tracking and reportingnot PathAI
  • Food safety and environmental testing laboratoriesnot PathAI
  • Multi-site laboratory networks standardising methods and specificationsnot PathAI

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

PathAI

  • AISight is labelled research use only and cannot be used for primary diagnosis; only AISight Dx carries the FDA clearance and CE-IVD mark, and laboratories regularly buy the wrong configuration and discover they cannot sign out on it.
  • The software licence is usually the smallest line in a digital pathology project, behind scanners, storage and network capacity, so a business case built around the software cost understates the real investment by a wide margin.
  • Whole slide images are very large, so a laboratory that does not model storage growth and retention policy from the start faces storage costs that grow faster than case volume and dominate the renewal.
  • Clinical validation is required per subspecialty rather than once for the platform, which means dermatopathology, gastrointestinal and breast each need their own concordance study and pathologist time before go live.
  • PathAI competes against pathology incumbents that also sell the scanners, and a laboratory buying an independent image management layer takes on the integration risk between scanner vendor and software vendor itself.

STARLIMS

  • Implementation is lengthy and outcome quality depends heavily on the partner doing the configuration
  • Pricing is quote-based with no public reference, making early budget setting difficult
  • The breadth across laboratory types means some verticals get less development attention than others
  • Interface modernisation has lagged behind newer cloud-native laboratory platforms
  • Over-specified for small laboratories, where a lighter LIMS delivers most of the value for a fraction of the effort

Pricing, plan by plan

PathAI

On request
  • AISight$undefined/year
    • Priced by annual slide or case volume and by pathologist seats
    • AISight Dx, the clinically cleared configuration, quoted separately from research use AISight
    • Image storage priced by capacity and retention policy

STARLIMS

On request
  • STARLIMS$undefined/year
    • Sample management
    • Quality management
    • Instrument integration

Which should you pick?

Choose PathAI if

  • You need aisight image management.
  • You also want aisight dx.
PathAI review

Choose STARLIMS if

  • You need sample and specimen management.
  • You work on Web, Windows, Cloud, On-premise.
  • You also want quality management.
STARLIMS review

Questions people ask

Is PathAI or STARLIMS better?
Neither clearly leads. PathAI starts at On request and STARLIMS at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, PathAI or STARLIMS?
PathAI starts at On request and STARLIMS at On request.
Does PathAI or STARLIMS run on more platforms?
PathAI runs on Web. STARLIMS runs on Web, Windows, Cloud, On-premise.
What is PathAI best used for?
PathAI is most often used for an academic medical centre going digital for primary diagnosis that needs the fda cleared aisight dx configuration rather than the research labelled version, a reference laboratory consolidating subspecialty sign out across sites so a specialist pathologist can read cases from any location, a pharmaceutical company needing consistent quantitative scoring of trial biopsies across many sites and readers, a laboratory with a mixed scanner estate that needs one image management layer rather than each scanner vendor viewer. Of those, an academic medical centre going digital for primary diagnosis that needs the fda cleared aisight dx configuration rather than the research labelled version and a reference laboratory consolidating subspecialty sign out across sites so a specialist pathologist can read cases from any location are not what STARLIMS is typically brought in for.
What can PathAI do that STARLIMS cannot?
PathAI covers AISight image management, AISight Dx, Scanner interoperability, Case and worklist management. STARLIMS covers Sample and specimen management, Quality management, Instrument integration, Public health reporting.

Answered from the vendors’ own pages

PathAI: What is the difference between AISight and AISight Dx?

AISight is for research use only and not for clinical diagnostic use. AISight Dx received FDA 510(k) clearance in June 2025 for primary diagnosis and is CE-IVD marked in the EEA, UK and Switzerland. Only the Dx configuration can be used to sign out cases.

STARLIMS: Who owns STARLIMS?

Abbott. That gives it institutional weight in laboratory procurement and a natural relationship with Abbott diagnostic instruments.

PathAI: Can we use our existing scanners?

Yes. AISight is designed to ingest images from multiple whole slide scanner vendors, which is one of the main reasons laboratories choose an independent image management layer.

STARLIMS: Where is it strongest?

Public health and clinical laboratories. Surveillance reporting, outbreak investigation and unpredictable specimen surges are different problems from pharmaceutical QC, and it handles them well.

PathAI: Do the AI algorithms carry the same clearance as the platform?

No. The platform clearance covers image management for primary diagnosis. Individual algorithms have their own labelling, and many are research use only. Check each one separately.

STARLIMS: What does it cost?

Not published. Enterprise licensing plus implementation, quoted on laboratory count, users and modules.

PathAI: Is pricing published?

No. It is quoted by slide or case volume, pathologist seats and storage, with the clinically cleared configuration priced separately.

STARLIMS: How does it compare to LabWare?

Both are enterprise LIMS with regulatory depth. LabWare is more dominant in pharmaceutical QC; STARLIMS has more presence in public health and clinical. Implementation partner quality matters more than the platform difference.

STARLIMS: What decides a successful implementation?

Configuration and validation quality, not platform features. Evaluations that compare feature lists rather than implementation approach are asking the wrong question.

Share

Related pages

More on PathAI

More on STARLIMS

Keep looking

Other head to heads